Open source drug discovery gets its day in the sun

10/24/2013 | Xconomy

Merck, Johnson & Johnson and Sanofi recently launched open source drug development projects that "represent a sea change in the pre-competitive landscape for pharmaceutical development," writes John Wilbanks, a senior fellow at FasterCures and chief commons officer at Sage Bionetworks. The open source movement in drug discovery is being driven by massive public investment in health and biology, as well as governmental and institutional momentum to open knowledge bases for reuse and recombination, Wilbanks writes. "This level of progress would have been unthinkable just a decade ago at the height of the first genomics bubble," he writes.

View Full Article in:

Xconomy

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ
Health Plan CEO – Oregon
Trillium Community Health Plan
Eugene, OR